Recipient IL28B genotype (HR for TT genotype, 1.27; 95% CI 1.04–1.56; p = 0.022), HCV status (HR 3.27; 95% CI 1.86–5.74; p<0.001), and diabetes (HR 12.86; 95% CI 5.17–32.07; p<0.001) were the only factors that significantly influenced graft survival. Here, IFNL3 is linked to diabetes mellitus.